Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-3167 Titration in Type 2 Diabetes
NCT07472725Phase 2Active, not recruiting
- Sponsor
- Hengrui
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-3167 in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Started Apr 2026; status: active, not recruiting.
02
Drugs
SHR-3167
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07472725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07472725.